Tomas Pala is the corporate affairs manager at Zentiva, where he leads the company’s engagement on EU policy, legislation, and public affairs. Representing Zentiva at the European level, he focuses on sustainability, pharmaceutical regulation, and market access. In addition to his role at Zentiva, Tomas serves as vice-chair of the Generics Market Access Committee at Medicines for Europe, actively contributing to industry discussions on the pharmaceutical environment and regulatory frameworks. With over a decade of experience in government and public affairs, he has worked extensively on issues related to industrial policy, supply chain resilience, and patient access to affordable medicines. His expertise lies in advocating for a competitive and sustainable European pharmaceutical industry, fostering collaboration with policymakers, industry stakeholders, and international organizations to advance solutions that enhance public health and economic resilience.
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.